The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 5.3% in the afternoon session after its first-quarter results, although beating expectations, were overshadowed by concerns about its future ...

Investors in 10x Genomics Inc (Symbol: TXG) saw new options become available this week, for the May 2025 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, ...

Investors in 10x Genomics Inc (Symbol: TXG) saw new options become available this week, for the August 2024 expiration. One of the key inputs that goes into the price an option buyer is willing to pay ...

10x Genomics (TXG) closed the last trading session at $8.86, gaining 7.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street ...

Biotech company 10x Genomics (NASDAQ:TXG) reported in Q1 CY2026, but sales fell by 2.6% year on year to $150.8 million. The company expects the full year’s revenue to be around $612.5 million, close ...

Total Q3 2024 revenue: $151.7 million, down 1% YoY Instruments revenue fell 46%, while consumables revenue grew 10% The next correction is closer than you think. Find out how Tom Gentile plans to ...

View 10x Genomics Inc Class A TXG stock quote prices, financial information, real-time forecasts, and company news from CNN.

Looking ahead to 2030, our model projects TXG could trade at an average price of $2,836.89, with a potential range between $2,127.67 and $3,546.12. This represents a potential 11,880.1% return from ...